Clinical Trials for 1ST Biotherapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: 1ST Biotherapeutics

Clinical Trials (3)

NCT07126704
A Phase 1, SAD and MAD to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral FB-101 in Healthy Adult Male Subjects
PHASE1Not yet recruiting
72 participants
Started: Nov 30, 2025 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT05995782
A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418
PHASE1Recruiting
64 participants
Started: Dec 20, 2023 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05761223
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
PHASE1/PHASE2Recruiting
151 participants
Started: Dec 13, 2023 · Completed: Oct 31, 2026
1 condition2 sponsors5 locations